Results
253
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
253 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SRPT | US$145.61 | -4.3% | 37.5% | US$13.6b | US$198.28 | PE814.6x | E39.9% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$117.93 | -8.8% | 166.2% | US$3.0t | US$136.60 | PE68x | E23.3% | 0.03% | Semiconductors | ||
ARES | US$147.30 | 3.3% | 45.1% | US$46.1b | US$151.50 | PE68.4x | E29.0% | 2.5% | Diversified Financials | ||
NU | US$13.47 | 0.4% | 70.1% | US$62.8b | US$13.55 | PB9.5x | E27.4% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$138.59 | 7.2% | 32.1% | US$166.9b | US$131.61 | PE53.4x | E27.5% | 2.4% | Diversified Financials | ||
PDD | US$133.04 | -6.6% | 75.1% | US$183.4b | US$207.21 | PE16.8x | E21.4% | n/a | Retail | ||
SMCI | US$796.78 | -12.4% | 162.8% | US$46.9b | US$1,035.32 | PE44.5x | E40.2% | n/a | Tech | ||
CG | US$45.94 | 6.3% | 32.5% | US$16.7b | US$48.30 | PS7.5x | E23.6% | 3.0% | Diversified Financials | ||
OWL | US$19.27 | 8.9% | 58.5% | US$27.2b | US$20.92 | PE141x | E88.2% | 3.7% | Diversified Financials | ||
SYM | US$39.19 | 2.1% | -10.3% | US$22.5b | US$55.79 | PS2.7x | E131.1% | n/a | Capital Goods | ||
LEGN | US$58.74 | 8.0% | -21.3% | US$10.6b | US$82.63 | PS31.2x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
NTNX | US$48.30 | -11.0% | 65.0% | US$11.8b | US$74.54 | PS5.7x | E82.8% | n/a | Software | ||
CHK | US$81.01 | -3.0% | -2.5% | US$10.7b | US$104.84 | PE10.1x | E37.4% | 3.0% | Energy | ||
SPOT | US$295.09 | -2.4% | 71.9% | US$57.8b | US$353.31 | PS3.9x | E40.1% | n/a | Media | ||
ALNY | US$237.83 | -8.7% | 18.9% | US$29.9b | US$254.83 | PS15x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
ZS | US$188.54 | -6.6% | 26.5% | US$28.8b | US$230.08 | PS14x | E50.9% | n/a | Software | ||
RYAN | US$57.27 | 0.5% | 24.7% | US$15.3b | US$60.08 | PE107.2x | E49.2% | 0.8% | Insurance | ||
TER | US$146.42 | -6.3% | 27.3% | US$23.3b | US$144.02 | PE53.2x | E23.8% | 0.3% | Semiconductors | ||
PTC | US$175.92 | -3.7% | 20.9% | US$21.1b | US$203.05 | PE73.2x | E22.8% | n/a | Software | ||
VRT | US$85.31 | -4.9% | 232.2% | US$30.9b | US$103.26 | PE79x | E30.3% | 0.1% | Capital Goods | ||
MPWR | US$808.83 | -5.5% | 51.6% | US$41.1b | US$831.95 | PE96x | E20.7% | 0.6% | Semiconductors | ||
HUBS | US$479.82 | 0.8% | -11.8% | US$24.5b | US$659.28 | PS10.7x | E59.6% | n/a | Software | ||
VIK | US$37.00 | 5.8% | n/a | US$15.8b | US$35.55 | PS3.4x | E91.5% | n/a | Consumer Services |